1. Home
  2. FOXF vs PRTA Comparison

FOXF vs PRTA Comparison

Compare FOXF & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fox Factory Holding Corp.

FOXF

Fox Factory Holding Corp.

HOLD

Current Price

$16.71

Market Cap

707.0M

ML Signal

HOLD

Logo Prothena Corporation plc

PRTA

Prothena Corporation plc

HOLD

Current Price

$10.82

Market Cap

539.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOXF
PRTA
Founded
2007
2012
Country
United States
Ireland
Employees
N/A
N/A
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
707.0M
539.9M
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
FOXF
PRTA
Price
$16.71
$10.82
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$30.25
$19.00
AVG Volume (30 Days)
614.3K
453.1K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,467,321,000.00
$814,000.00
Revenue This Year
N/A
$1,111.38
Revenue Next Year
$0.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.27
N/A
52 Week Low
$13.08
$4.32
52 Week High
$31.18
$11.69

Technical Indicators

Market Signals
Indicator
FOXF
PRTA
Relative Strength Index (RSI) 47.78 67.15
Support Level $15.42 $9.69
Resistance Level $18.21 $10.90
Average True Range (ATR) 0.84 0.40
MACD 0.10 0.10
Stochastic Oscillator 39.97 96.87

Price Performance

Historical Comparison
FOXF
PRTA

About FOXF Fox Factory Holding Corp.

Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World. The company operates in three segments: Powered Vehicles Group, Aftermarket Applications Group, and Specialty Sports Group, of which it derives maximum revenue from Specialty Sports Group segment.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. Prothena is developing and applying its proprietary CYTOPE technology to target a broad spectrum of intracellular disease pathways in the brain and periphery. The company's pipeline includes both wholly-owned and partnered programs like Prasinezumab, Coramitug (PRX004), BMS-986446 (PRX005), PRX019, TDP-43 CYTOPE, and PRX012-TfR, being developed for the potential treatment of Parkinson's disease, ATTR amyloidosis with cardiomyopathy, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.

Share on Social Networks: